Machine vision-assisted analysis of structure-localization relationships in a combinatorial library of prospective bioimaging probes

Cytometry Part A

Volumn 75, Issue 6, 2009, Pages 482-493

  Shedden, Kerby ^a   Li, Qian ^b   Liu, Fangyi ^a   Young, Tae Chang ^c,d   Rosania, Gus R ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b NEW YORK UNIVERSITY   (United States)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d AGENCY FOR SCIENCE   (Singapore)

Author keywords

Bioimaging; Cheminformatics; Combinatorial chemistry; Fluorescence; High content screening; Image cytometry; Machine vision; Styryl

Indexed keywords

ALDEHYDE; FLUORESCENT DYE; PYRIDINIUM DERIVATIVE; QUINOLINE DERIVATIVE; STYRYL MOLECULE; UNCLASSIFIED DRUG;

ARTICLE; CELLULAR DISTRIBUTION; COMBINATORIAL LIBRARY; CONTROLLED STUDY; FLUORESCENCE; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IMAGING SYSTEM; ISOMER; MACHINE; MECHANICAL PROBE; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCREENING; SYNTHESIS;

ALDEHYDES; ALGORITHMS; COMBINATORIAL CHEMISTRY TECHNIQUES; FLOW CYTOMETRY; FLUORESCENT DYES; HELA CELLS; HUMANS; MICROSCOPY, FLUORESCENCE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 66449100042     PISSN: 15524922     EISSN: 15524930     Source Type: Journal    
DOI: 10.1002/cyto.a.20713     Document Type: Article

References (54)

1. Blake JF. Chemoinformatics - predicting the physicochemical properties of 'drug-like' molecules. Curr Opin Biotechnol 2000;11:104-107. (Pubitemid 30099047)
2. Ghose AK, Crippen GM. Quantitative structure-activity relationship by distance geometry: Quinazolines as dihydrofolate reductase inhibitors. J Med Chem 1982;25:892-899. (Pubitemid 13231853)
3. Ghose AK, Crippen GM. Use of physicochemical parameters in distance geometry and related three-dimensional quantitative structure-activity relationships: A demonstration using Escherichia coli dihydrofolate reductase inhibitors. J Med Chem 1985;28:333-346. (Pubitemid 15137939)
4. Ghose AK, Crippen GM. Modeling the benzodiazepine receptor binding site by the general three-dimensional structure-directed quantitative structure-activity relationship method REMOTEDISC. Mol Pharmacol 1990;37:725-734. (Pubitemid 20171509)
5. Marrero Ponce Y, Cabrera Perez MA, Romero Zaldivar V, Gonzalez Diaz H, Torrens F. A new topological descriptors based model for predicting intestinal epithelial transport of drugs in Caco-2 cell culture. J Pharm Pharm Sci 2004;7:186-199. (Pubitemid 41528891)
6. McFarland JW, Berger CM, Froshauer SA, Hayashi SF, Hecker SJ, Jaynes BH, Jefson MR, Kamicker BJ, Lipinski CA, Lundy KM, Reese CP, Vu CB. Quantitative structure-activity relationships among macrolide antibacterial agents: In vitro and in vivo potency against Pasteurella multocida. J Med Chem 1997;40:1340-1346.
7. Svetnik V, Liaw A, Tong C, Culberson JC, Sheridan RP, Feuston BP. Random forest: A classification and regression tool for compound classification and QSAR modeling. J Chem Inf Comput Sci 2003;43:1947-1958.
8. Wildman SA, Crippen GM. Three-dimensional molecular descriptors and a novel QSAR method. J Mol Graph Model 2002;21:161-170. (Pubitemid 35279847)
9. Hansch C. The QSAR paradigm in the design of less toxic molecules. Drug Metab Rev 1984;15:1279-1294. (Pubitemid 15028345)
10. Hansch C, Leo A.Exploring QSAR: Fundamentals and Applications in Chemistry and Biology. Washington DC: American Chemical Society; 1995.
11. Leo A, Hansch C, Church C. Comparison of parameters currently used in the study of structure-activity relationships. J Med Chem 1969;12:766-771.
12. Colston J, Horobin RW, Rashid-Doubell F, Pediani J, Johal KK. Why fluorescent probes for endoplasmic reticulum are selective: An experimental and QSAR-modelling study. Biotech Histochem 2003;78:323-332. (Pubitemid 38821296)
13. Horobin RW. Structure-staining relationships in histochemistry and biological staining. Part 3. Some comments on the intentional and artifactual staining of lipids. Acta Histochem Suppl 1981;24:237-246.
14. Horobin RW. Structure-staining relationships in histochemistry and biological staining. I. Theoretical background and a general account of correlation of histochemical staining with the chemical structure of the reagents used. J Microsc 1980;119:345-355.
15. Horobin RW, Flemming L. Structure-staining relationships in histochemistry and biological staining. II. Mechanistic and practical aspects of the staining of elastic fibres. J Microsc 1980;119:357-372. (Pubitemid 10010601)
16. Horobin RW, Rashid F. Interactions of molecular probes with living cells and tissues. Part 1. Some general mechanistic proposals, making use of a simplistic Chinese box model. Histochemistry 1990;94:205-209.
17. Rashid F, Horobin RW Accumulation of fluorescent non-cationic probes in mitochondria of cultured cells: Observations, a proposed mechanism, and some implications. J Microsc 1991;163(Pt 2):233-241.
18. Rashid F, Horobin RW. Interaction of molecular probes with living cells and tissues. Part 2. A structure-activity analysis of mitochondrial staining by cationic probes, and a discussion of the synergistic nature of image-based and biochemical approaches. Histochemistry 1990;94:303-308.
19. Rashid F, Horobin RW, Williams MA. Predicting the behaviour and selectivity of fluorescent probes for lysosomes and related structures by means of structure-activity models. Histochem J 1991;23:450-459.
20. Boland MV, Murphy RF. A neural network classifier capable of recognizing the patterns of all major subcellular structures in fluorescence microscope images of HeLa cells. Bioinformatics 2001;17:1213-1223. (Pubitemid 33735348)
21. Chen X, Murphy RF. Objective clustering of proteins based on subcellular location patterns. J Biomed Biotechnol 2005;2005:87-95. (Pubitemid 41627864)
22. Hu Y, Murphy RF. Automated interpretation of subcellular patterns from immunofluorescence microscopy. J Immunol Methods 2004;290:93-105. (Pubitemid 38917133)
23. Murphy RF. Automated interpretation of protein subcellular location patterns: Implications for early cancer detection and assessment. Ann NY Acad Sci 2004;1020:124-131. (Pubitemid 38736930)
24. Murphy RF, Boland MV, Velliste M. Towards a systematics for protein subcelluar location: Quantitative description of protein localization patterns and automated analysis of fluorescence microscope images. Proc Int Conf Intell Syst Mol Biol 2000;8:251-259.
25. Roques EJ, Murphy RF. Objective evaluation of differences in protein subcellular distribution. Traffic 2002;3:61-65. (Pubitemid 34567268)
26. Posada MM, Shedden K, Chang YT, Li Q, Rosania GR.Prospecting for Live Cell Bioimaging Probes with Cheminformatic Assisted Image Arrays. 4th IEEE International Symposium on Biomedical Imaging: From Nano to Macro, ISBI 2007, 12-15 April, 2007. pp 1108-1111.
27. Blake RA. Cellular screening assays using fluorescence microscopy. Curr Opin Pharmacol 2001;1:533-539. (Pubitemid 33593845)
28. Lee JW, Jung M, Rosania GR, Chang YT. Development of novel cell-permeable DNA sensitive dyes using combinatorial synthesis and cell-based screening. Chem Commun (Camb) 2003;7:1852-1853. (Pubitemid 36920730)
29. Li Q, Kim Y, Namm J, Kulkarni A, Rosania GR, Ahn YH, Chang YT. RNA-selective, live cell imaging probes for studying nuclear structure and function. Chem Biol 2006;13:615-623. (Pubitemid 43912455)
30. Shedden K, Xie XT, Chandaroy P, Chang YT, Rosania GR. Expulsion of small molecules in vesicles shed by cancer cells: Association with gene expression and chemosensitivity profiles. Cancer Res 2003;63:4331-4337. (Pubitemid 36950999)
31. Bereiter-Hahn J. Dimethylaminostyrylmethylpyridiniumiodine (daspmi) as a fluorescent probe for mitochondria in situ. Biochim Biophys Acta 1976;423:1-14.
32. Li Q, Lee JS, Ha C, Park CB, Yang G, Gan WB, Chang YT. Solid-phase synthesis of styryl dyes and their application as amyloid sensors. Angew Chem Int Ed Engl 2004;43:6331-6335. (Pubitemid 40029464)
33. Li Q, Min J, Ahn YH, Namm J, Kim EM, Lui R, Kim HY, Ji Y, Wu H, Wisniewski T, Chang YT. Styryl-based compounds as potential in vivo imaging agents for beta-amyloid plaques. Chembiochem 2007;8:1679-1687. (Pubitemid 47523672)
34. Mewes HW, Rafael J. The 2-(dimethylaminostyryl)-1-methylpyridinium cation as indicator of the mitochondrial membrane potential. FEBS Lett 1981;131:7-10.
35. Vida TA, Emr SD. A new vital stain for visualizing vacuolar membrane dynamics and endocytosis in yeast. J Cell Biol 1995;128:779-792.
36. Rosania GR, Lee JW, Ding L, Yoon HS, Chang YT. Combinatorial approach to organelle-targeted fluorescent library based on the styryl scaffold. J Am Chem Soc 2003;125:1130-1131. (Pubitemid 36159799)
37. Shedden K, Brumer J, Chang YT, Rosania GR. Chemoinformatic analysis of a super-targeted combinatorial library of styryl molecules. J Chem Inf Comput Sci 2003;43:2068-2080.
38. Wang M, Gao M, Miller KD, Sledge GW, Hutchins GD, Zheng QH. Simple synthesis of carbon-11 labeled styryl dyes as new potential PET RNA-specific, living cell imaging probes. Eur J Med Chem (in press).
39. Abraham VC, Taylor DL, Haskins JR. High content screening applied to large-scale cell biology. Trends Biotechnol 2004;22:15-22. (Pubitemid 38030316)
40. Chen VY, Khersonsky SM, Shedden K, Chang YT, Rosania GR. System dynamics of subcellular transport. Mol Pharm 2004;1:414-425.
41. Conway BR, Minor LK, Xu JZ, Gunnet JW, DeBiasio R, D'Andrea MR, Rubin R, DeBiasio R, Giuliano K, DeBiasio L, Demarest KT. Quantification of G-protein coupled receptor internatilization using G-protein coupled receptor-green fluorescent protein conjugates with the ArrayScantrade mark high-content screening system. J Biomol Screen 1999;4:75-86. (Pubitemid 29278955)
42. Giuliano KA. High-content profiling of drug-drug interactions: Cellular targets involved in the modulation of microtubule drug action by the antifungal ketoconazole. J Biomol Screen 2003;8:125-135. (Pubitemid 40503615)
43. Giuliano KA, Chen YT, Taylor DL. High-content screening with siRNA optimizes a cell biological approach to drug discovery: Defining the role of P53 activation in the cellular response to anticancer drugs. J Biomol Screen 2004;9:557-568. (Pubitemid 40503514)
44. Giuliano KA, Haskins JR, Taylor DL. Advances in high content screening for drug discovery. Assay Drug Dev Technol 2003;1:565-577.
45. Trapp S, Rosania GR, Horobin RW, Kornhuber J. Quantitative modeling of selective lysosomal targeting for drug design. Eur Biophys J 2008;37:1317-1328.
46. Zhang X, Shedden K, Rosania GR. A cell-based molecular transport simulator for pharmacokinetic prediction and cheminformatic exploration. Mol Pharm 2006;3:704-716. (Pubitemid 46087486)
47. Trapp S, Horobin RW. A predictive model for the selective accumulation of chemicals in tumor cells. Eur Biophys J 2005;34:959-966. (Pubitemid 41428192)
48. Xu JJ, Henstock PV, Dunn MC, Smith AR, Chabot JR, de Graaf D. Cellular imaging predictions of clinical drug-induced liver injury. Toxicol Sci 2008;105:97-105.
49. Ihlenfeldt WD, Voigt JH, Bienfait B, Oellien F, Nicklaus MC. Enhanced CACTVS browser of the open NCI database. J Chem Inf Comput Sci 2002;42:46-57. (Pubitemid 35355324)
50. Keij JF, Bell-Prince C, Steinkamp JA. Staining of mitochondrial membranes with 10-nonyl acridine orange. MitoFluor Green, and MitoTracker Green is affected by mitochondrial membrane potential altering drugs. Cytometry 2000;39:203-210.
51. Huang K, Murphy RF. From quantitative microscopy to automated image understanding. J Biomed Opt 2004;9:893-912. (Pubitemid 41268671)
52. Murphy RF. Cytomics and location proteomics: Automated interpretation of subcellular patterns in fluorescence microscope images. Cytometry A 2005;67:1-3. (Pubitemid 41318287)
53. Murphy RF. Location proteomics: A systems approach to subcellular location. Biochem Soc Trans 2005;33(Pt 3):535-538. (Pubitemid 40873881)
54. Rosania GR. Supertargeted chemistry: Identifying relationships between molecular structures and their sub-cellular distribution. Curr Top Med Chem 2003;3:659-685.